Skip to main content

Table 4 Clinical and biological characteristics of the NB cohort used for pyrosequencing validation

From: Two independent epigenetic biomarkers predict survival in neuroblastoma

 

INRG staging system

Characteristics

L1

L2

M

MS

Total

Number of patients

12

21

42

8

83

Patients over 18 months at diagnostic

3

8

38

0

49

Sex

 Female

8

6

16

3

33

 Male

4

15

26

5

50

MYCN status

 Amplified (%)

0

8 (38%)

16 (38%)

1 (12.5%)

25 (30%)

 Not amplified (%)

12 (100%)

13 (62%)

23 (55%)

7 (87.5%)

55 (66%)

 Not determined (%)

0

0

3 (7%)

0

3 (4%)

Patients with relapse (%)

3 (25%)

5 (24%)

22 (52%)

0

30 (36%)

Dead (%)

0

6 (29%)

25 (60%)

0

31 (37%)